Studies clarifying the effect of NPY on the pathophysiological mechanism underlying chronic IH-induced vascular ED identify NPY as a potential target for the treatment of OSAS-related cerebrovascular diseases. This evidence concerns the gene NPY and cerebrovascular disorder.